Skip to main content

Stress Echocardiography with Vasoactive Agents

  • Chapter
Stress Echocardiography

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 149))

  • 40 Accesses

Abstract

Exercise and dobutamine stress induce ischemia by increasing myocardial oxygen requirements to a level which exceeds the ability of a stenosed coronary artery to satisfy the increased demand (see Chapters 3 and 4). Ischemia in most ambulatory situations is caused by oxygen demand outstripping supply, but it may be combined with reduction in coronary supply due to vasospasm or coronary steal. This “supply-side” ischemia may be replicated during stress testing, either using dipyridamole as a convenient form of pharmacologic stress, or using ergotamine to specifically investigate the presence of a vasoactive mechanism of ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Knabb RM, Gidday JM, Ely SW, Rubio R, Berne RM. Effects of dipyridamole on myocardial adenosine and active hyperemia. Am J Physiol 1984;247: H804–H810.

    PubMed  CAS  Google Scholar 

  2. Klabunde RE. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 1983;9: 21–26.

    Article  Google Scholar 

  3. Wilson RF, White CW. Intracoronary papaverine: An ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986;73: 444–451.

    Article  PubMed  CAS  Google Scholar 

  4. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82: 1595–1606.

    Article  PubMed  CAS  Google Scholar 

  5. Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 1990;81: 1205–1209.

    Article  PubMed  CAS  Google Scholar 

  6. Wendt VE, Sundermeyer JF, Denbakker PB, Bing RJ. The relationship between coronary blood flow, myocardial oxygen consumption and cardiac work as influenced by persantin. Am J Cardiol 1962;9: 449–455.

    Article  PubMed  CAS  Google Scholar 

  7. Wilcken DEL, Paolini HJ, Eickens E. Evidence for intravenous dipyridamole producing a “coronary steal” effect in the ischaemic myocardium. Aust NZ J Med 1971;1: 8–10.

    Article  CAS  Google Scholar 

  8. Picano E. Dipyridamole echocardiography test: Historical background and physiological basis. Eur Heart J 1989;10: 365–376.

    PubMed  CAS  Google Scholar 

  9. Albro PC, Gould KL, Westcott RJ, Hamilton GV, Ritchie JL, Williams DL. Non-invasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. III Clinical trial. Am J Cardiol 1978;42: 751–760.

    Article  PubMed  CAS  Google Scholar 

  10. Picano E, Lattanzi F. Dipyridamole echocardiography: A new diagnostic window on coronary artery disease. Circulation 1991;83 (Suppl III): 19–26.

    Google Scholar 

  11. Gross GJ, Warltier DC. Coronary steal in four models of single or multiple vessel obstruction in dogs. Am J Cardiol 1981;48: 84–92.

    Article  PubMed  CAS  Google Scholar 

  12. Marwick T, Torelli J, Underwood D, Maclntyre WJ. Metabolic evidence of ischemia following high-and low-dose dipyridamole stress [abstract]. J Nucl Med 1992;33: 866.

    Google Scholar 

  13. Smits P, Corstens FH, Aengevaeren WR, Wackers FJ, Thien T. False negative dipyridamole thallium-201 myocardial imaging after caffeine infusion. J Nucl Med 1991;32: 1538–1541.

    PubMed  CAS  Google Scholar 

  14. Brown BG, Josephson MA, Petersen RB et al. Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease]. Am J Cardiol 1981;48: 1077–1

    Article  PubMed  CAS  Google Scholar 

  15. Cohen JL, Greene TO, Alston JR, Wilchford SD, Kim CS. Usefulness of oral dipyridamole digital echocardiography for detecting coronary artery disease. Am J Cardiol 1989;64: 385–386.

    Article  PubMed  CAS  Google Scholar 

  16. Picano E, Lattanzi F, Massini M, Distante A, L’Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986;8: 848–854.

    Article  PubMed  CAS  Google Scholar 

  17. Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease. J Am Coll Cardiol 1991; 18:736–745.

    Article  PubMed  CAS  Google Scholar 

  18. Nguyen T, Heo J, Ogilby JD, Iskandrian AS. Single-photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: Correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography. J Am Coll Cardiol 1990;16: 1375–1383.

    Article  PubMed  CAS  Google Scholar 

  19. Zoghbi WA, Cheirif J, Kleiman NS, Verani MS, Trakhtenbroit A. Diagnosis of ischemic heart disease with adenosine echocardiography. J Am Coll Cardiol 1991;18: 1271–1279.

    Article  PubMed  CAS  Google Scholar 

  20. Marwick T, Willemart B, D’Hondt AM et al. Selection of the optimal non-exercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion: Comparison of dobutamine and adenosine using echocardiography and Tc-99 m MIBI Single Photon Emission Computed Tomography. Circulation 1993;87: 345–354.

    Article  PubMed  CAS  Google Scholar 

  21. Mazeika P, Nihoyannopoulos P, Joshi J, Oakley CM. Uses and limitations of high dose dipyridamole stress echocardiography for evaluation of coronary artery disease. Br Heart J 1992;67: 144–149.

    Article  PubMed  CAS  Google Scholar 

  22. Picano E, Distante A, Masini M, Morales MA, Lattanzi F, L’Abbate A. Dipyridamole echocardiography test in effort angina pectoris. Am J Cardiol 1985;56: 452–456.

    Article  PubMed  CAS  Google Scholar 

  23. Picano E, Marini C, Pirelli S et al. Safety of intravenous high-dose dipyridamole echocardiography. Am J Cardiol 1992;70: 252–258.

    Article  PubMed  CAS  Google Scholar 

  24. Masini M, Picano E, Lattanzi F, Distante A, L’Abbate A. High-dose dipyridamole echocardiography test in women: Correlation with exercise-electrocardiography test and coronary arteriography. J Am Coll Cardiol 1988;12: 682–685.

    Article  PubMed  CAS  Google Scholar 

  25. Picano E, Severi S, Lattanzi F et al. The diagnostic and prognostic value of echo-dipyridam-ole in patients with suspected coronary disease. G Ital Cardiol 1991;21: 621–632.

    PubMed  CAS  Google Scholar 

  26. Massa D, Pirelli S, Gara E et al. Exercise testing and dipyridamole echocardiography test before and 48h after successful coronary angioplasty: Prognostic implications. Eur Heart J 1989;10(Suppl G): 13–17.

    Article  PubMed  Google Scholar 

  27. Picano E, Lattanzi F, Masini M, Distante A, L’ Abbate A. Usefulness of the dipyridamole-exercise echocardiography test for diagnosis of coronary artery disease. Am J Cardiol 1988;62: 67–70.

    Article  PubMed  CAS  Google Scholar 

  28. Agati L, Arata L, Neja CP et al. Usefulness of dipyridamole-Doppler test for diagnosis of coronary artery disease. Am J Cardiol 1990;65: 829–834.

    Article  PubMed  CAS  Google Scholar 

  29. Labovitz AJ, Pearson AC, Chaitman BR. Doppler and two-dimensional echocardiographic assessment of left ventricular function before and after intravenous dipyridamole stress testing for detection of coronary artery disease. Am J Cardiol 1988;62: 1180–1185.

    Article  PubMed  CAS  Google Scholar 

  30. Pingitore A, Picano E, Kozakova M et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography [abstract]. Circulation 1992;85: 1–863.

    Article  Google Scholar 

  31. Agati L, Renzi M, Sciomer S et al. Transesophageal dipyridamole echocardiography for diagnosis of coronary artery disease. J Am Coll Cardiol 1992;19: 765–770.

    Article  PubMed  CAS  Google Scholar 

  32. Previtali M, Lanzarini L, Ferrario M, Tortorici M, Mussini A, Montemartini C. Dobutamine versus dipyridamole echocardiography in coronary artery disease. Circulation 1991;83(Suppl III): 27–31.

    Google Scholar 

  33. Lattanzi F, Picano E, Bolognese L et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans: Correlation with exercise echocardiography. Circulation 1991;83: 1256–1262.

    Article  PubMed  CAS  Google Scholar 

  34. Kern MJ, Pearson AC, Labovitz AJ et al. Effects of pharmacologic coronary hyperemia on echocardiographic left ventricular function in patients with single vessel coronary disease. J Am Coll Cardiol 1989;13: 1042–1051.

    Article  PubMed  CAS  Google Scholar 

  35. Grayburn PA, Popma JL, Pryor SL, Walker BS, Simon TR, Smitherman TC. Comparison of dipyridamole Doppler echocardiography to thallium-201 imaging and quantitative coronary arteriography in the assessment of coronary artery disease. Am J Cardiol 1989;63: 1315–1320.

    Article  PubMed  CAS  Google Scholar 

  36. Mazeika P, Nihoyannopoulos P, Joshi J, Oakley CM. Evaluation of dipyridamole-Doppler echocardiography for detection of myocardial ischemia and coronary artery disease. Am J Cardiol 1991;68: 478–484

    Article  PubMed  CAS  Google Scholar 

  37. Picano E, Severi S, Michelassi C et al. Prognostic importance of dipyridamole echocardiography test in coronary artery disease. Circulation 1989;80: 450–457.

    Article  PubMed  CAS  Google Scholar 

  38. Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A. Different degrees of ischemic threshold stratified by the dipyridamole echocardiography test. Am J Cardiol 1987;59: 71–73.

    Article  PubMed  CAS  Google Scholar 

  39. Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR. Comparison of adenosine, dipyridamole and dobutamine in stress echocardiography. Ann Intern Med 1992; 116: 190–196.

    PubMed  CAS  Google Scholar 

  40. Picano E. Stress echocardiography — From pathophysiological toy to diagnostic tool. Circulation 1992;85: 1604–1612.

    Article  PubMed  CAS  Google Scholar 

  41. Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A. Comparison of the high-dose dipyridamole echocardiography test and exercise two-dimensional echocardiography for diagnosis of coronary artery disease. Am J Cardiol 1987;59: 539–554.

    Article  PubMed  CAS  Google Scholar 

  42. Previtali M, Ardissino D, Barberis P, Panciroli C, Chimienti M, Salerno JA. Hyperventilation and ergonovine tests in Prinzmetal’s variant angina pectoris in man. Am J Cardiol 1989;63: 17–20.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Marwick, T. (1994). Stress Echocardiography with Vasoactive Agents. In: Stress Echocardiography. Developments in Cardiovascular Medicine, vol 149. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0782-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-0782-2_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4335-9

  • Online ISBN: 978-94-011-0782-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics